White Paper

Naloxone: Guideline-based Recommendations for Opioid Patients in Outpatient Community Settings

Naloxone is considered to be one of several essential tools for the prevention of opioid overdose deaths.

White Paper Summary

Naloxone: Guideline-based Recommendations for Opioid Patients in Outpatient Community Settings
by Suzanne Novak, MD, PhD

The purpose of this document is to thoroughly describe naloxone for opioid overdose reversal, including how it works, contemporary formulations and dosing (including approximate average cost range), and current efforts to increase drug availability in outpatient community settings. This is followed by a detailed discussion of targeted prescribing of naloxone in a community clinical setting, particularly to those patients prescribed opioids for legitimate pain control (both acute and chronic).

Register to download the full content

 

To learn more about ODG by MCG, please visit their website.

ODG, an MCG Health company, provides unbiased, evidence-based guidelines that unite payers, providers, and employers in the effort to confidently and effectively return employees to health.

More from Risk & Insurance

More from Risk & Insurance

Risk Matrix: Presented by Liberty Mutual Insurance

9 Trends that Are Driving Rate Increases

The market was optimistically cautious entering 2020, but thanks to COVID-19, growing liability challenges and other risk factors, we’re seeing more hardening.
By: | September 1, 2020




The R&I Editorial Team can be reached at [email protected]